PharVision Advisers’s Robinhood HOOD Stock Holding History

PharVision Advisers’s Portfolio HOOD Stock Details HOOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,957	Closed	-$221K	–	348
2025 Q4	$221K	Buy	+1,957	New	+$255K	0.11%	475

Other funds holding HOOD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NMO

Newlands Management Operations Dallas, Texas $15.5B AUM 25.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IVAV

Index Venture Associates VI St. Helier, Channel Islands, Jersey $2.11B AUM 13.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PharVision Advisers's HOOD Position: Q1 2026 in Review

PharVision Advisers sold out of Robinhood (HOOD) in Q1 2026, closing a stake of 1,957 shares — an estimated $221K sold.

PharVision Advisers first reported a position in HOOD in Q4 2025 and held it in 1 quarter. The position peaked at $221K in Q4 2025. 1,262 funds tracked by Wall St. Rank hold HOOD as of Q1 2026.

PharVision Advisers reported no remaining Robinhood position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,957 Robinhood shares in Q1 2026, an estimated $221K.
PharVision Advisers first reported a position in Robinhood in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Robinhood position peaked at $221K in Q4 2025.
1,262 funds tracked by Wall St. Rank held Robinhood as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.